Literature DB >> 15283207

Construction of recombinant fowlpox viruses carrying multiple vaccine antigens and immunomodulatory molecules.

David B Boyle1, Mary-Ann Anderson, Rachel Amos, Rhonda Voysey, Barbara E H Coupar.   

Abstract

Here we describe plasmid vectors and selection protocols developed to allow the construction of recombinant fowlpox viruses (rFPVs) with up to three insertions of foreign DNA in the viral genome. Transient dominant selection allows the construction of recombinant viruses that do not retain the selection markers and can therefore be used for the insertion of additional genes at other sites in the viral genome. A SYBR Green real-time PCR sequence detection assay was applied to the identification of recombinant viruses from individual plaques, eliminating the need for amplification and hybridization from the transient dominant protocol and resulting in significant savings in time at each round of plaque purification. Dominant selection techniques allow more rapid recombinant virus construction; however, as the markers are retained along with the gene of interest, they can only be used to generate the final recombinant. rFPV vaccines constructed using these techniques have reached preclinical nonhuman primate and phase I human clinical trials in prime/boost vaccination studies as human immunodeficiency virus (HIV) therapeutic andprophylactic vaccines.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15283207     DOI: 10.2144/04371RR02

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  11 in total

1.  Induction of both cellular and humoral immunity following a rational prime-boost immunization regimen that incorporates recombinant ovine atadenovirus and fowlpox virus.

Authors:  Cara K Fraser; Kerrilyn R Diener; Erin L Lousberg; Gerald W Both; Larry Ward; Michael P Brown; John D Hayball
Journal:  Clin Vaccine Immunol       Date:  2010-09-01

2.  Comparative efficacy of subtype AE simian-human immunodeficiency virus priming and boosting vaccines in pigtail macaques.

Authors:  Robert De Rose; C Jane Batten; Miranda Z Smith; Caroline S Fernandez; Viv Peut; Scott Thomson; Ian A Ramshaw; Barbara E H Coupar; David B Boyle; Vanessa Venturi; Miles P Davenport; Stephen J Kent
Journal:  J Virol       Date:  2006-10-18       Impact factor: 5.103

3.  An HIV-1 clade A/E DNA prime, recombinant fowlpox virus boost vaccine is safe, but non-immunogenic in a randomized phase I/IIa trial in Thai volunteers at low risk of HIV infection.

Authors:  Atchriya Hemachandra; Rebekah L Puls; Sunee Sirivichayakul; Stephen Kerr; Pattarawat Thantiworasit; Sasiwimol Ubolyam; David A Cooper; Sean Emery; Praphan Phanuphak; Anthony Kelleher; Kiat Ruxrungtham
Journal:  Hum Vaccin       Date:  2010-10-01

4.  A comparative analysis of HIV-specific mucosal/systemic T cell immunity and avidity following rDNA/rFPV and poxvirus-poxvirus prime boost immunisations.

Authors:  Charani Ranasinghe; Fiona Eyers; John Stambas; David B Boyle; Ian A Ramshaw; Alistair J Ramsay
Journal:  Vaccine       Date:  2011-02-23       Impact factor: 3.641

5.  Efficacy of DNA and fowlpox virus priming/boosting vaccines for simian/human immunodeficiency virus.

Authors:  C J Dale; R De Rose; I Stratov; S Chea; D C Montefiori; S Thomson; I A Ramshaw; B E H Coupar; D B Boyle; M Law; S J Kent
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

6.  Different levels of immunogenicity of two strains of Fowlpox virus as recombinant vaccine vectors eliciting T-cell responses in heterologous prime-boost vaccination strategies.

Authors:  Matthew G Cottingham; Andre van Maurik; Manola Zago; Angela T Newton; Richard J Anderson; M Keith Howard; Jörg Schneider; Michael A Skinner
Journal:  Clin Vaccine Immunol       Date:  2006-07

Review 7.  Novel viral vectored vaccines for the prevention of influenza.

Authors:  Teresa Lambe
Journal:  Mol Med       Date:  2012-10-24       Impact factor: 6.354

Review 8.  Avipoxviruses: infection biology and their use as vaccine vectors.

Authors:  Simon C Weli; Morten Tryland
Journal:  Virol J       Date:  2011-02-03       Impact factor: 4.099

9.  Recombinant fowlpox virus vector-based vaccines: expression kinetics, dissemination and safety profile following intranasal delivery.

Authors:  David G Townsend; Shubhanshi Trivedi; Ronald J Jackson; Charani Ranasinghe
Journal:  J Gen Virol       Date:  2017-04-01       Impact factor: 3.891

Review 10.  Antigen delivery systems for veterinary vaccine development. Viral-vector based delivery systems.

Authors:  Alejandro Brun; Emmanuel Albina; Tom Barret; David A G Chapman; Markus Czub; Linda K Dixon; Günther M Keil; Bernard Klonjkowski; Marie-Frédérique Le Potier; Geneviève Libeau; Javier Ortego; Jennifer Richardson; Haru-H Takamatsu
Journal:  Vaccine       Date:  2008-12-02       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.